News
RXST
16.56
+1.41%
0.23
4 Best Breakout Stocks to Buy Now for Superlative Returns
NASDAQ · 1h ago
RxSight: Disrupting The Premium Intraocular Lens Market
Seeking Alpha · 21h ago
How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69%
NASDAQ · 03/13 13:55
5 Analysts Have This to Say About RxSight
Benzinga · 03/07 15:00
JP Morgan Maintains Overweight on RxSight, Lowers Price Target to $20
Benzinga · 03/07 13:22
Needham Remains a Buy on RxSight (RXST)
TipRanks · 03/07 12:25
--JPMorgan Adjusts Price Target on RxSight to $20 From $22, Maintains Overweight Rating
--JPMorgan Adjusts Price Target on RxSight to $20 From $22, Maintains Overweight Rating
MT Newswires · 03/07 08:57
Update: RxSight Q4 Adjusted Loss Shrinks as Sales Almost Double; Needham Reiterates Buy
Update: RxSight Q4 Adjusted Loss Shrinks as Sales Almost Double; Needham Reiterates Buy
MT Newswires · 03/07 06:50
RxSight (RXST) Receives a Buy from BTIG
TipRanks · 03/07 02:05
BRIEF-Rxsight, Inc. Reports Q4 And Full Year 2022 Financial Results
Reuters · 03/06 23:40
RxSight Non-GAAP EPS of -$0.45 beats by $0.29, revenue of $16.1M in-line, guidance above consensus
Seeking Alpha · 03/06 21:12
RxSight Q4 Adjusted Loss Narrows as Revenue Increases; Sets Fiscal 2023 Revenue Guidance
RxSight Q4 Adjusted Loss Narrows as Revenue Increases; Sets Fiscal 2023 Revenue Guidance
MT Newswires · 03/06 17:59
Earnings Scheduled For March 6, 2023
Benzinga · 03/06 09:52
Earnings Preview: RxSight
Benzinga · 03/03 17:00
Needham Keeps Their Buy Rating on RxSight (RXST)
TipRanks · 03/03 12:25
$6M Bet On RxSight? Check Out These 3 Stocks Insiders Are Buying
Benzinga · 02/14 13:34
Insider Buy: Rxsight
Insider Buy: Rxsight
MT Newswires · 02/14 07:49
Alphabet, Capri Holdings, Paycom Software And Other Big Stocks Moving Lower On Wednesday
Benzinga · 02/08 15:16
Why RxSight Shares Are Plummeting
Benzinga · 02/08 14:15
RxSight slumps on pricing $50M common stock offering
Seeking Alpha · 02/08 10:59
More
Webull provides a variety of real-time RXST stock news. You can receive the latest news about Rxsight, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About RXST
RxSight, Inc. is a commercial-stage medical technology company. The Company is engaged in improving the vision of patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.